• Reference Citation Analysis
  • v
  • v
  • Find an Article
  • Find an Author
Download
Number Citation Analysis
1
Garcia P, Jürgens‐Wemheuer W, Uriarte Huarte O, Michelucci A, Masuch A, Brioschi S, Weihofen A, Koncina E, Coowar D, Heurtaux T, Glaab E, Balling R, Sousa C, Kaoma T, Nicot N, Pfander T, Schulz‐Schaeffer W, Allouche A, Fischer N, Biber K, Kleine‐Borgmann F, Mittelbronn M, Ostaszewski M, Schmit KJ, Buttini M. Neurodegeneration and neuroinflammation are linked, but independent of alpha‐synuclein inclusions, in a seeding/spreading mouse model of Parkinson's disease. Glia 2022;70:935-960. [PMID: 35092321 PMCID: PMC9305192 DOI: 10.1002/glia.24149] [Citation(s) in RCA: 21] [Impact Index Per Article: 10.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/22/2020] [Revised: 01/07/2022] [Accepted: 01/13/2022] [Indexed: 12/16/2022]
2
Sabri O, Catafau A, Barthel H, Ishii K, Rowe CC, Leverenz J, Ghetti BF, Ironside J, Takao M, Akatsu H, Murayama S, Koglin N, Schulz‐Schaeffer W, Sabbagh M, Stephens A, Seibyl J. P2‐225: POSTMORTEM HISTOPATHOLOGY‐PROOFED EFFICACY AND RELIABILITY OF THE VISUAL ASSESSMENT OF 18F‐FLORBETABEN PET SCANS IN THE DETECTION OF CEREBRAL BETA‐AMYLOID NEURITIC PLAQUES. Alzheimers Dement 2014. [DOI: 10.1016/j.jalz.2014.05.902] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
3
Seibyl J, Sabri O, Sabbagh M, Akatsu H, Ouchi Y, Beach T, Charny A, Barthel H, Senda K, Murayama S, Ishii K, Leverenz J, Ghetti B, Ironside J, Roth K, Reininger C, Hoffmann A, Schulz‐Schaeffer W. P4‐167: Techniques for histopathological verification of florbetaben PET in a global phase III clinical trial. Alzheimers Dement 2012. [DOI: 10.1016/j.jalz.2012.05.1871] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
4
Sabbagh M, Seibyl J, Akatsu H, Ouchi Y, Beach T, Charny A, Barthel H, Senda K, Muryama S, Iishi K, Leverenz J, Ghetti B, Ironside J, Roth K, Hoffmann A, Schulz‐Schaeffer W, Reininger C, Sabri O. O1‐04‐01: Multicentre phase 3 trial on florbetaben for beta‐amyloid brain PET in Alzheimer's disease. Alzheimers Dement 2012. [DOI: 10.1016/j.jalz.2012.05.220] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
5
Bibl M, Esselmann H, Mollenhauer B, Trenkwalder C, Schulz‐Schaeffer W, Kretzschmar H, Otto M, Wiltfang J. P1‐132: CSF Aβ peptides in neuropathologically diagnosed dementias with lewy bodies and Alzheimer's type. Alzheimers Dement 2011. [DOI: 10.1016/j.jalz.2011.05.412] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
PrevPage 1 of 1 1Next
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA